Literature DB >> 21034379

Febrile convulsions after 2010 seasonal trivalent influenza vaccine: implications for vaccine safety surveillance in Australia.

Michael S Gold, Paul Effler, Heath Kelly, Peter C Richmond, Jim P Buttery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21034379     DOI： 10.5694/j.1326-5377.2010.tb04029.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  9 in total

1.  Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.

Authors:  Hazel J Clothier; Nigel W Crawford; Melissa Russell; Heath Kelly; Jim P Buttery
Journal:  Drug Saf       Date:  2017-06       Impact factor: 5.606

2.  Prevalence of recent immunisation in children with febrile convulsions.

Authors:  Leya Motala; Guy D Eslick
Journal:  World J Clin Pediatr       Date:  2016-08-08

3.  Acute disseminated encephalomyelitis and routine childhood vaccinations - a self-controlled case series.

Authors:  T J Martin; M Fahey; M Easton; H J Clothier; R Samuel; N W Crawford; J P Buttery
Journal:  Hum Vaccin Immunother       Date:  2021-04-09       Impact factor: 3.452

4.  Short and long-term safety of the 2009 AS03-adjuvanted pandemic vaccine.

Authors:  Gaston De Serres; Marie-Claude Gariépy; Brenda Coleman; Isabelle Rouleau; Shelly McNeil; Mélanie Benoît; Allison McGeer; Ardith Ambrose; Judy Needham; Chantal Bergeron; Cynthia Grenier; Kenna Sleigh; Arlene Kallos; Manale Ouakki; Najwa Ouhoummane; Grant Stiver; Louis Valiquette; Anne McCarthy; Julie Bettinger
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

5.  Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study.

Authors:  Peter Jacoby; Catherine Glover; Chloe Damon; Parveen Fathima; Alexis Pillsbury; David Durrheim; Michael S Gold; Alan Leeb; Tom Snelling
Journal:  BMJ Open       Date:  2020-03-01       Impact factor: 2.692

6.  From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years.

Authors:  Anastasia Phillips; Samantha Carlson; Margie Danchin; Frank Beard; Kristine Macartney
Journal:  Vaccine       Date:  2021-08-08       Impact factor: 3.641

7.  Vaccine safety: what systems are required to ensure public confidence in vaccines?

Authors:  Allen C Cheng; Jim P Buttery
Journal:  Med J Aust       Date:  2022-07-17       Impact factor: 12.776

8.  Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia.

Authors:  Hazel J Clothier; Jock Lawrie; Melissa A Russell; Heath Kelly; Jim P Buttery
Journal:  PLoS One       Date:  2019-11-01       Impact factor: 3.240

9.  The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada.

Authors:  Julie A Bettinger; Manish Sadarangani; Gaston De Serres; Louis Valiquette; Otto G Vanderkooi; James D Kellner; Matthew P Muller; Karina A Top; Jennifer E Isenor; Allison McGeer; Kimberly Marty
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.